Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Turcot syndrome × dostarlimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 14 Endometrial Neoplasms 14 Carcinoma, Non-Small-Cell Lung 9 Ovarian Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasm Metastasis 6 Uterine Cervical Neoplasms 5 Head and Neck Neoplasms 5 Melanoma 4 Colonic Neoplasms 4 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Breast Neoplasms 3 Stomach Neoplasms 2 Osteosarcoma 2 Multiple Myeloma 2 Lung Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Neuroendocrine 2 Carcinoma 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Sarcoma, Clear Cell 1 Sarcoma 1

Interventions

pembrolizumab 9 Nivolumab 8 Neoadjuvant Therapy 3 Ipilimumab 3 sintilimab 2 durvalumab 2 avelumab 2 atezolizumab 2 Immune Checkpoint Inhibitors 2 toripalimab 1 tislelizumab 1 spartalizumab 1 relatlimab 1 regorafenib 1 fludarabine phosphate 1 fludarabine 1 dostarlimab 1 denileukin diftitox 1 danvatirsen 1 Taxes 1 Surgical Procedures, Operative 1 Specimen Handling 1 Radiation Dose Hypofractionation 1 Paclitaxel 1 Oxaliplatin 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Magnetic Resonance Spectroscopy 1 Leucovorin 1 Irinotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06278857 2024-12-03

SATELLITE

Queensland Centre for Gynaecological Cancer

Phase 2 Recruiting

Turcot syndrome, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡